Jinjun Shan1, Jiashuang Zou2, Tong Xie3, An Kang2, Wei Zhou3, Haishan Deng3, Yancao Mao2, Liuqing Di1, Shouchuan Wang3. 1. Jiangsu Key Laboratory of Pediatric Respiratory Disease, Institute of Pediatrics, China ; Jiangsu Engineering Research Center for Efficient Delivery System of TCM, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China. 2. Jiangsu Engineering Research Center for Efficient Delivery System of TCM, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China. 3. Jiangsu Key Laboratory of Pediatric Respiratory Disease, Institute of Pediatrics, China.
Abstract
BACKGROUND: Platycodi radix, the dried root of Platycodon grandiflorum A. DC, has been widely used as food and herb medicine for treating cough, cold and other respiratory ailments, and platycodin D (PD) is one of the most important compounds in Platycodi Radix. OBJECTIVE: The purpose of this study was to compare the pharmacokinetic characteristics, intestinal absorption and microbial metabolism of PD in monomer with that in Platycodi radix extract (PRE). MATERIALS AND METHODS: In the pharmacokinetic study, the concentrations of PD in rat plasma were determined by ultra-performance liquid chromatography-tandem mass spectrometry and the main pharmacokinetic parameters were calculated by data analysis software (DAS). Besides, in vitro Caco-2 cells and fecal lysate were performed to investigate the intestinal absorption and metabolism, respectively. RESULTS: The results from pharmacokinetics showed that the area under the curve, the peak concentration the time to reach peak concentration and mean residence time of PD in PRE were enhanced significantly compared with that in single PD. Caco-2 cells transport study indicated that the absorption of PD both in monomer and in PRE were poor owning that the permeability of PD were <1/10(6) cm/s. The hydrolysis degree of PD in PRE was significantly lower than that in monomer PD in fecal lysate, which might be illustrated by the other ingredients in PRE influenced the hydrolysis of PD via gut microbiota. CONCLUSION: These findings indicated that the difference of microbial metabolism, not apparent absorption in intestine for PD between in monomer and in PRE contributed to their pharmacokinetic difference.
BACKGROUND: Platycodi radix, the dried root of Platycodon grandiflorum A. DC, has been widely used as food and herb medicine for treating cough, cold and other respiratory ailments, and platycodin D (PD) is one of the most important compounds in Platycodi Radix. OBJECTIVE: The purpose of this study was to compare the pharmacokinetic characteristics, intestinal absorption and microbial metabolism of PD in monomer with that in Platycodi radix extract (PRE). MATERIALS AND METHODS: In the pharmacokinetic study, the concentrations of PD in rat plasma were determined by ultra-performance liquid chromatography-tandem mass spectrometry and the main pharmacokinetic parameters were calculated by data analysis software (DAS). Besides, in vitro Caco-2 cells and fecal lysate were performed to investigate the intestinal absorption and metabolism, respectively. RESULTS: The results from pharmacokinetics showed that the area under the curve, the peak concentration the time to reach peak concentration and mean residence time of PD in PRE were enhanced significantly compared with that in single PD. Caco-2 cells transport study indicated that the absorption of PD both in monomer and in PRE were poor owning that the permeability of PD were <1/10(6) cm/s. The hydrolysis degree of PD in PRE was significantly lower than that in monomer PD in fecal lysate, which might be illustrated by the other ingredients in PRE influenced the hydrolysis of PD via gut microbiota. CONCLUSION: These findings indicated that the difference of microbial metabolism, not apparent absorption in intestine for PD between in monomer and in PRE contributed to their pharmacokinetic difference.
Entities:
Keywords:
Intestinal absorption; Platycodi radix; microbial metabolism; pharmacokinetics; platycodin D
Authors: Tao Niu; Diane L Smith; Zhen Yang; Song Gao; Taijun Yin; Zhi-Hong Jiang; Ming You; Richard A Gibbs; Joseph F Petrosino; Ming Hu Journal: Pharm Res Date: 2012-12-20 Impact factor: 4.200
Authors: Wei Zhou; Xuan Xuan Zhu; Ai Ling Yin; Bao Chang Cai; Hai Dan Wang; Liuqing Di; Jin Jun Shan Journal: Pharmacogn Mag Date: 2014-01 Impact factor: 1.085
Authors: Hyung Jin Ahn; Hyun Ju You; Myung Su Park; Tony V Johnston; Seockmo Ku; Geun Eog Ji Journal: Int J Mol Sci Date: 2018-09-08 Impact factor: 5.923
Authors: Yu-Jeong Choi; Sol Ji Lee; Hyo In Kim; Hee Jung Lee; So Jung Kang; Tai Young Kim; Chunhoo Cheon; Seong-Gyu Ko Journal: Sci Rep Date: 2020-11-16 Impact factor: 4.379